
Amanta Healthcare vs Nifty 50: Share Price Performance Compared
Amanta Healthcare share price Rs 197.91 on NSE. Amanta Healthcare vs Nifty 50 over 1 year: +39.62% vs -2.41%. 52-week high Rs 205.57, low Rs 92.00.
Updated: 7 Sept 2026 • 5:09 pm
Posted by:

Quick Answer
Amanta Healthcare vs Nifty 50 shows Amanta Healthcare ahead of the benchmark on a one-year view, gaining +39.62% against the Nifty 50's -2.41%. With limited comparable trading history, longer-term comparisons against the Nifty 50 are not yet meaningful for this stock. Investors comparing the two should also weigh Amanta Healthcare's trading liquidity, valuation and sector context rather than relying on returns alone.
Amanta Healthcare vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Amanta Healthcare trades on the NSE under the symbol AMANTA, and its 1M return of +19.12% compares with the Nifty 50's -1.44% over the same period.
The Amanta Healthcare vs Nifty 50 comparison matters because Amanta Healthcare is a single stock exposed to its own sector and company-specific developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Amanta Healthcare share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year, using NSE closing data.
Click Here – Get Free Investment Predictions
Amanta Healthcare vs Nifty 50: Performance at a Glance
The table below sets out Amanta Healthcare vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 7 September 2026.
| Time Frame | Amanta Healthcare Return | Nifty 50 Return | Difference |
|---|---|---|---|
| 1 Month | +19.12% | -1.44% | +20.56% pp |
| 3 Months | +51.25% | +2.78% | +48.47% pp |
| 6 Months | +99.75% | -3.35% | +103.1% pp |
| 1 Year | +39.62% (Amanta Healthcare) | -2.41% (Nifty 50) | +42.03% pp |
On the Amanta Healthcare vs Nifty 50 scorecard, Amanta Healthcare has stayed ahead of the index over the most recent one-year window. With limited comparable trading history, longer-term comparisons against the Nifty 50 are not yet meaningful for this stock.
Check the Univest Screener for live Amanta Healthcare and Nifty 50 data
Why the Amanta Healthcare vs Nifty 50 Gap Exists
Amanta Healthcare's stock can move quite differently from the Nifty 50 because it carries concentrated exposure to its own sector and business cycle, unlike the index which blends 50 companies across banking, IT, energy and consumer sectors. This is the main driver of the gap seen in the Amanta Healthcare vs Nifty 50 return table above.
A second factor behind the Amanta Healthcare vs Nifty 50 divergence is valuation and trading liquidity. Company-specific news, quarterly results and sector sentiment can move Amanta Healthcare's price sharply in either direction over short periods, while the Nifty 50's return reflects the blended earnings trajectory of its constituents and is far less exposed to any single stock's swings.
Download the Univest iOS App or Univest Android App to track Amanta Healthcare and Nifty 50 live on the go.
Amanta Healthcare vs Nifty 50: Has Amanta Healthcare Beaten the Benchmark?
Amanta Healthcare has beaten the Nifty 50 over the past year, gaining +39.62% against the index's -2.41% over the same period.
Risks of the Amanta Healthcare vs Nifty 50 Comparison
Reading too much into a Amanta Healthcare vs Nifty 50 comparison has real limitations that investors should weigh before drawing conclusions. Amanta Healthcare carries concentrated business and sector risk that a diversified index does not, and its trading volumes and price swings can differ meaningfully from the Nifty 50's more liquid, blended profile. A stock's 52-week range of Rs 92.00 to Rs 205.57 also shows the kind of volatility that a single-stock investment carries relative to a broad index.
Conclusion
Amanta Healthcare vs Nifty 50 highlights how a single stock's return path can differ from a diversified benchmark over different time horizons. Investors weighing the Amanta Healthcare vs Nifty 50 record should factor in Amanta Healthcare's volatility, liquidity and sector concentration alongside its return history, and consult a SEBI-registered advisor before making an allocation decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Has Amanta Healthcare outperformed the Nifty 50 in the last year?
Ans. Yes. Amanta Healthcare gained +39.62% over the past year while the Nifty 50 returned -2.41% over the same period, based on NSE closing prices to 7 September 2026.
What is the Amanta Healthcare share price today compared to Nifty 50?
Ans. Amanta Healthcare share price stood at Rs 197.91 on NSE, while the Nifty 50 traded at 24,031.60 based on the same closing data window.
What is the 52-week high and low of Amanta Healthcare?
Ans. Amanta Healthcare's 52-week high is Rs 205.57 and its 52-week low is Rs 92.00, based on NSE data.
Why does Amanta Healthcare show bigger price swings than the Nifty 50?
Ans. Amanta Healthcare carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies, so company-specific news moves Amanta Healthcare's price more sharply than the diversified index, a key reason the Amanta Healthcare vs Nifty 50 return gap varies across time frames.
Is Amanta Healthcare a good long-term investment compared to a Nifty 50 index fund?
Ans. Amanta Healthcare's suitability depends on an investor's risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund; long-term investors should weigh the Amanta Healthcare vs Nifty 50 return history alongside the company's fundamentals and consult a SEBI-registered advisor.
Recent Articles
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Anuh Pharma: Should You Buy, Hold, or Sell Right Now?
Apcotex Industries: Should You Buy, Hold, or Sell Right Now?
Apollo Pipes: Should You Buy, Hold, or Sell Right Now?
Apex Frozen Foods: Should You Buy, Hold, or Sell Right Now?
Aptech: Should You Buy, Hold, or Sell Right Now?
Popular this week
Apollo Sindoori Hotels: Should You Buy, Hold, or Sell Right Now?

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





